Nocturnal saturation and glucose tolerance in children with cystic fibrosis

Thorax

Volumn 66, Issue 7, 2011, Pages 574-578

  Suratwala, Dharmeshkumar ^a   Chan, June S H ^b   Kelly, Andrea ^a   Meltzer, Lisa J ^a   Gallagher, Paul R ^a   Traylor, Joel ^a   Rubenstein, Ronald C ^a   Marcus, Carole L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOSE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTRACELLULAR ADHESION MOLECULE; OXYHEMOGLOBIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE;

ACTIMETRY; ADOLESCENT; ADULT; AGE; AREA UNDER THE CURVE; AROUSAL; ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIABETES MELLITUS; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; LUNG FUNCTION; MALE; NOCTURNAL OXYGEN SATURATION; ORAL GLUCOSE TOLERANCE TEST; OXYGEN SATURATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SLEEP QUALITY;

EID: 79959287073     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2010.142141     Document Type: Article

References (34)

1. Moran A, Dunitz J, Nathan B, et al. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care 2009;32:1626-31.
2. O'Riordan SM, Robinson PD, Donaghue KC, et al. Management of cystic fibrosis-related diabetes in children and adolescents. Pediatr Diabetes 2009;12(10 Suppl):43-50.
3. Hardin DS, Leblanc A, Marshall G, et al. Mechanisms of insulin resistance in cystic fibrosis. Am J Physiol Endocrinol Metab 2001;281:E1022-8.
4. Koch C, Rainisio M, Madessani U, et al. Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 2001;32:343-50. (Pubitemid 33015650)
5. Ip MS, Lam B, Ng MM, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002;165:670-6. (Pubitemid 34194755)
6. Somers VK, Dyken ME, Clary MP, et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995;96:1897-904.
7. Vgontzas AN, Chrousos GP. Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders. Endocrinol Metab Clin North Am 2002;31:15-36. (Pubitemid 34578612)
8. Louis M, Punjabi NM. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol 2009;106:1538-44.
9. Amin R, Bean J, Burklow K, et al. The relationship between sleep disturbance and pulmonary function in stable pediatric cystic fibrosis patients. Chest 2005;128:1357-63. (Pubitemid 41324418)
10. Jankelowitz L, Reid KJ, Wolfe L, et al. Cystic fibrosis patients have poor sleep quality despite normal sleep latency and efficiency. Chest 2005;127:1593-9. (Pubitemid 46218783)
11. Tauman R, O'Brien LM, Gozal D. Hypoxemia and obesity modulate plasma C-reactive protein and interleukin-6 levels in sleep-disordered breathing. Sleep Breath 2007;11:77-84. (Pubitemid 46745859)
12. Htoo AK, Greenberg H, Tongia S, et al. Activation of nuclear factor kappaB in obstructive sleep apnea: a pathway leading to systemic inflammation. Sleep Breath 2006;10:43-50. (Pubitemid 44193436)
13. El Sheikh M, Buckhalt JA, Granger DA, et al. The association between children's sleep disruption and salivary interleukin-6. J Sleep Res 2007;16:188-97. (Pubitemid 46850095)
14. Ohga E, Nagase T, Tomita T, et al. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 1999;87:10-14. (Pubitemid 29330658)
15. O'Brien LM, Serpero LD, Tauman R, et al. Plasma adhesion molecules in children with sleep-disordered breathing. Chest 2006;129:947-53.
16. Meier-Ewert HK, Ridker PM, Rifai N, et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 2004;43:678-83. (Pubitemid 38229544)
17. Vgontzas AN, Zoumakis E, Bixler EO, et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 2004;89:2119-26. (Pubitemid 38619840)
18. Deepa R, Velmurugan K, Arvind K, et al. Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance - the Chennai Urban Rural Epidemiology Study (CURES). Metabolism 2006;55:1232-8. (Pubitemid 44215943)
19. Nixon LS, Yung B, Bell SC, et al. Circulating immunoreactive interleukin-6 in cystic fibrosis. Am J Respir Crit Care Med 1998;157:1764-9.
20. Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 2000;162:891-5.
21. Melendres MC, Lutz JM, Rubin ED, et al. Daytime sleepiness and hyperactivity in children with suspected sleep-disordered breathing. Pediatrics 2004;114:768-75. (Pubitemid 41529537)
22. Iber C, Ancoli-Israel S, Chesson AL, et al. The AASM Manual for the Scoring of Sleep and Associated Events: Rule, Terminology and Technical Specifications. Westchster, IL: American Academy of Sleep Medicine, 2007.
23. Ode KL, Frohnert B, Laguna T, et al. Oral glucose tolerance testing in children with cystic fibrosis. Pediatr Diabetes 2010;11:487-92.
24. Moran A, Doherty L, Wang X, et al. Abnormal glucose metabolism in cystic fibrosis. J Pediatr 1998;133:10-17. (Pubitemid 28323899)
25. Dobson L, Sheldon CD, Hattersley AT. Conventional measures underestimate glycaemia in cystic fibrosis patients. Diabet Med 2004;21:691-6. (Pubitemid 38916212)
26. Iannucci A, Mukai K, Johnson D, et al. Endocrine pancreas in cystic fibrosis: an immunohistochemical study. Hum Pathol 1984;15:278-84. (Pubitemid 15162478)
27. Stamatakis K, Sanders MH, Caffo B, et al. Fasting glycemia in sleep disordered breathing: lowering the threshold on oxyhemoglobin desaturation. Sleep 2008;31:1018-24. (Pubitemid 351956941)
28. Braun B, Rock PB, Zamudio S, et al. Women at altitude: short-term exposure to hypoxia and/or alpha(1)-adrenergic blockade reduces insulin sensitivity. J Appl Physiol 2001;91:623-31.
29. Iyer NV, Kotch LE, Agani F, et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 1998;12:149-62. (Pubitemid 28060446)
30. Yokoe T, Alonso LC, Romano LC, et al. Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic beta-cell replication in mice. J Physiol 2008;586:899-911. (Pubitemid 351194126)
31. Moritz W, Meier F, Stroka DM, et al. Apoptosis in hypoxic human pancreatic islets correlates with HIF-1alpha expression. FASEB J 2002;16:745-47.
32. Kopelman LM, Murphy TF. Ethical concerns about federal approval of risky pediatric studies. Pediatrics 2004;113:1783-9. (Pubitemid 38697992)
33. Code of Federal Regulations. 45 CFR 46:401-409. Additional protections for children involved as subjects in research. (Subpart D: US Department of Health and Human Services. In. Fed Reg). 1983:9816-20. http://ohsr.od.nih.gov/ guidelines/45cfr46.html#46.401.
34. Department of Health EaWNCftPoHSoBaBR. Research Involving Children Report and Recommendation. Washington, DC: Department of Health, Education and Welfare, (Publication no. [OS] 77-0004). 1977.